Colgate-Palmolive (NYSE:CL) Shares Sold by InterOcean Capital LLC

InterOcean Capital LLC cut its position in Colgate-Palmolive (NYSE:CL) by 32.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,486 shares of the company’s stock after selling 2,169 shares during the quarter. InterOcean Capital LLC’s holdings in Colgate-Palmolive were worth $298,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Firestone Capital Management acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $89,000. Advisory Alpha LLC purchased a new position in shares of Colgate-Palmolive during the 1st quarter valued at approximately $26,000. Peddock Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $34,000. Pacifica Partners Inc. acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Finally, West Bancorporation Inc. bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $38,000. 74.79% of the stock is owned by institutional investors and hedge funds.

Several research analysts have weighed in on the stock. Bank of America raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a report on Friday, March 20th. SunTrust Banks lifted their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, May 15th. TheStreet lowered Colgate-Palmolive from a “b” rating to a “c+” rating in a report on Friday, May 1st. Morgan Stanley increased their target price on Colgate-Palmolive from $72.00 to $78.00 and gave the stock an “overweight” rating in a report on Monday, April 27th. Finally, Stifel Nicolaus boosted their price target on Colgate-Palmolive from $72.00 to $75.00 and gave the company a “buy” rating in a report on Monday, May 4th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $75.60.

In related news, VP Philip G. Shotts sold 666 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $75.61, for a total value of $50,356.26. Following the sale, the vice president now directly owns 41,158 shares in the company, valued at approximately $3,111,956.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Michael B. Polk sold 3,115 shares of Colgate-Palmolive stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $68.08, for a total value of $212,069.20. Following the sale, the director now directly owns 20,622 shares in the company, valued at approximately $1,403,945.76. The disclosure for this sale can be found here. Insiders have sold a total of 80,132 shares of company stock valued at $5,774,879 over the last three months. 0.78% of the stock is currently owned by company insiders.

NYSE:CL traded up $0.49 during midday trading on Friday, reaching $70.75. 3,427,409 shares of the company traded hands, compared to its average volume of 4,410,119. The firm has a market capitalization of $60.18 billion, a price-to-earnings ratio of 24.15, a price-to-earnings-growth ratio of 4.62 and a beta of 0.60. The company has a fifty day moving average price of $69.93 and a 200 day moving average price of $69.58. The company has a debt-to-equity ratio of 21.51, a current ratio of 0.96 and a quick ratio of 0.66. Colgate-Palmolive has a twelve month low of $58.49 and a twelve month high of $77.41.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, May 1st. The company reported $0.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.73 by $0.02. Colgate-Palmolive had a return on equity of 942.99% and a net margin of 15.86%. The company had revenue of $4.10 billion for the quarter, compared to analysts’ expectations of $4.07 billion. During the same period last year, the business posted $0.67 earnings per share. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive will post 2.87 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a $0.44 dividend. The ex-dividend date of this dividend was Friday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a yield of 2.49%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 62.19%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Book Value Per Share – BVPS

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.